Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Systemic Assessment of CIPN Risk Using Molecular Aging Trajectories

NCT04932031 is registered in ClinicalTrials.gov with Sapere Bio as lead sponsor.

NCT NCT04932031
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04932031 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Systemic Assessment of CIPN Risk Using Molecular Aging Trajectories
Lead sponsor
Sapere Bio
Phase
Observational
Overall status
Terminated
Start date
May 25, 2022
Completion date
November 1, 2023
Enrollment
123 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

aging, breast cancer, chemotherapy-induced peripheral neuropathy